Literature DB >> 25270580

Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.

François Debaene1, Amandine Boeuf, Elsa Wagner-Rousset, Olivier Colas, Daniel Ayoub, Nathalie Corvaïa, Alain Van Dorsselaer, Alain Beck, Sarah Cianférani.   

Abstract

Antibody drug conjugates (ADCs) are macromolecules composed of cytotoxic drugs covalently attached via a conditionally stable linker to monoclonal antibodies (mAbs). ADCs are among the most promising next generation of empowered mAbs foreseen to treat cancers. Compared to naked mAbs, ADCs have an increased level of complexity as the heterogeneity of conjugation cumulates with the inherent microvariability of the biomolecule. An increasing need underlying ADC's development and optimization is to improve its analytical and bioanalytical characterization by assessing three main ADC quality attributes: drug distribution, amount of naked antibody, and average drug to antibody ratio (DAR). Here, the analytical potential of native mass spectrometry (MS) and native ion mobility MS (IM-MS) is compared to hydrophobic interaction chromatography (HIC), the reference method for quality control of interchain cysteinyl-linked ADCs. Brentuximab vedotin, first in class and gold standard, was chosen for a proof of principle. High resolution native MS provided accurate mass measurement (<30 ppm) of intact ADCs together with average DAR and drug distribution, confirming the unique ability of native MS for simultaneous detection of mixtures of covalent and noncovalent products. Native IM-MS was next used for the first time to characterize an ADC. IM-MS evidenced ADC multiple drug loading, collisional cross sections measurement of each payload species attesting slight conformational changes. A semiquantitative interpretation of IM-MS data was developed to directly extrapolate average DAR and DAR distribution. Additionally, HIC fractions were collected and analyzed by native MS and IM-MS, assessing the interpretation of each HIC peak. Altogether, our results illustrate how native MS and IM-MS can rapidly assess ADC structural heterogeneity and how easily these methods can be implemented into MS workflows for in-depth ADC analytical characterization.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25270580     DOI: 10.1021/ac502593n

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  40 in total

1.  Standard Proteoforms and Their Complexes for Native Mass Spectrometry.

Authors:  Luis F Schachner; Ashley N Ives; John P McGee; Rafael D Melani; Jared O Kafader; Philip D Compton; Steven M Patrie; Neil L Kelleher
Journal:  J Am Soc Mass Spectrom       Date:  2019-04-08       Impact factor: 3.109

2.  Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates.

Authors:  Richard Y-C Huang; Ekaterina G Deyanova; David Passmore; Vangipuram Rangan; Shrikant Deshpande; Adrienne A Tymiak; Guodong Chen
Journal:  J Am Soc Mass Spectrom       Date:  2015-06-30       Impact factor: 3.109

3.  Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates.

Authors:  Thomas Botzanowski; Stéphane Erb; Oscar Hernandez-Alba; Anthony Ehkirch; Olivier Colas; Elsa Wagner-Rousset; David Rabuka; Alain Beck; Penelope M Drake; Sarah Cianférani
Journal:  MAbs       Date:  2017-04-13       Impact factor: 5.857

4.  Localized conformational interrogation of antibody and antibody-drug conjugates by site-specific carboxyl group footprinting.

Authors:  Lucy Yan Pan; Oscar Salas-Solano; John F Valliere-Douglass
Journal:  MAbs       Date:  2016-12-08       Impact factor: 5.857

Review 5.  Strategies and challenges for the next generation of antibody-drug conjugates.

Authors:  Alain Beck; Liliane Goetsch; Charles Dumontet; Nathalie Corvaïa
Journal:  Nat Rev Drug Discov       Date:  2017-03-17       Impact factor: 84.694

6.  Quantitative collision-induced unfolding differentiates model antibody-drug conjugates.

Authors:  Yuwei Tian; Jennifer L Lippens; Chawita Netirojjanakul; Iain D G Campuzano; Brandon T Ruotolo
Journal:  Protein Sci       Date:  2018-12-22       Impact factor: 6.725

7.  Analysis of Proteins, Protein Complexes, and Organellar Proteomes Using Sheathless Capillary Zone Electrophoresis - Native Mass Spectrometry.

Authors:  Arseniy M Belov; Rosa Viner; Marcia R Santos; David M Horn; Marshall Bern; Barry L Karger; Alexander R Ivanov
Journal:  J Am Soc Mass Spectrom       Date:  2017-09-05       Impact factor: 3.109

Review 8.  Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.

Authors:  Olga V Friese; Jacquelynn N Smith; Paul W Brown; Jason C Rouse
Journal:  MAbs       Date:  2018-02-20       Impact factor: 5.857

9.  High Mass Analysis with a Fourier Transform Ion Cyclotron Resonance Mass Spectrometer: From Inorganic Salt Clusters to Antibody Conjugates and Beyond.

Authors:  Iain D G Campuzano; Michael Nshanian; Christopher Spahr; Carter Lantz; Chawita Netirojjanakul; Huilin Li; Piriya Wongkongkathep; Jeremy J Wolff; Joseph A Loo
Journal:  J Am Soc Mass Spectrom       Date:  2020-04-02       Impact factor: 3.109

10.  Uniting Native Capillary Electrophoresis and Multistage Ultraviolet Photodissociation Mass Spectrometry for Online Separation and Characterization of Escherichia coli Ribosomal Proteins and Protein Complexes.

Authors:  M Rachel Mehaffey; Qiangwei Xia; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2020-11-06       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.